News About: Pharm. Industry
MSD to reduce the price of Zocor 40mg tablet by 1,200 won
MSD Korea said that it will reduce the current price of Zocor (simvastatin) 40mg, antihyperlipidemic, to 1,800 won per tablet from 1,200 won through its price readjustment application to the Health Insurance Review Ag...
European Commission clears Pfizer acquisition of Pharmacia with proviso
The Financial Times of the U.K. reported that Pfizer Inc's acquisition of Pharmacia Corp. for $54 billion in stock was approved by the European Commission on February 27 under the conditions that some launched items a...
Dong-A turns its eyes to Chinese market
Dong-A says it newly established Wuhan Donghe Pharma, a joint venture firm, with Donghe Corporation under the same 50:50 equity ratio of investment amounting to a total $250,000 in an effort to market Dong-A's own dru...
Mr. Lee Jang-han was elected to KPMA chairman.Mr. Lee Jang-han, Chairman of Chongkundang, was unanimously elected to the chairman of the KPMA board of directors at 2 p.m. on Feb. 26 in the 58th general congress of the KPMA ...
|
KPMA must transform to be a policy making organization.
It is urgently suggested for the KPMA to be transformed as a policy making organization in order to support for a sound progress of the pharmaceutical industry. It is pointed out that major roles of the KPMA shall not...
Bio Tech company, Celtrion to produce AIDS vaccines.
Celtrion, a joint venture company between American VaxGen Inc. and other Korean investors, announced on Feb. 25 that they would construct a production facility at Songdo, a new town in Incheon for the production of bi...
Pharmaceuticals, one of key nation's strategic industries.
The pharmaceutical industry, a high value added industry, should be fostered as one of the core national strategic industries in terms of its economic contribution.
Chairman Yu Seung-pil of the KPMA board of direct...
Domestic drug industry lacking efficient "Brand" management.
It is widely prevailed that the brand management by the domestic pharmaceutical industry appeared with far substandard level compared to other advanced countries.
Under the circumstances that a better "Brand" imag...
Novartis Korea to offer cash compensation program for leukemia patients in Korea
The Korea Orphan Drug Center said that those patients taking Glivec from this February will benefit from Novartis Korea's compensation program to cover patient's out-of-pocket of Glivec's treatment costs by ten percen...
Yuhan awarded Economic Justice Enterprise Prize
Yuhan Corporation was selected as the most prominent pharmaceutical firm from the 12th Economic Justice Enterprise Prize ceremony that was hosted by the Korea Economic Justice Institute under Citizens' Coalition for E...
